The FDA has classified a recall of more than 2.5 million bottles of prescription prednisolone acetate eye drops as Class II after the product was found to contain a foreign substance.
The recall affects 2,530,182 bottles of Prednisolone Acetate Ophthalmic Suspension, USP, 1% in 5 milliliter, 10 milliliter and 15 milliliter presentations manufactured by Lupin Limited and distributed nationwide, according to a June 30 enforcement report.
The voluntary recall was initiated June 4 and classified by the FDA on June 30. It remains ongoing. The affected products include multiple lots with expiration dates ranging from July through October 2026.
The recall follows a similar one in March, when K.C. Pharmaceuticals recalled more than 3.1 million bottles of over-the-counter eye drops, including store-brand products sold at CVS Health, Walgreens, Kroger and Cardinal Health, after the company could not verify the sterility of the products.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
